Funded by the National Institute for Health and Care Research and Innovate UK, the Advanced Therapy Clinical Trials Capability Framework, produced jointly by the Advanced Therapy Treatment Centre (ATTC) network, the Cell and Gene Therapy Catapult and Skills for Health, provides a shared strategic resource to support decision making across advanced therapy clinical trials services. 

Matthew Durdy, chief executive of the Cell and Gene Therapy Catapult, said: ‘Advanced therapies treat the root cause of a range of diseases and disorders, including cancer, sickle cell disease and spinal muscular atrophy.

‘The creation of an advanced therapy capability framework, as part of a national Advanced Therapy Medicinal Product Training and Education programme, will help address the existing challenge around a lack of therapy specific knowledge across trial delivery, research and support service workforces.

‘Having this framework in place represents a significant step towards expanding the workforce dedicated to advanced therapy clinical trials and scaling up the delivery of cell and gene therapy treatments across the NHS.'

To find out more visit: www.skillsforhealth.org.uk/ATCT-framework